• Return to Headlines

Top 5 Companies in the Biotechnology Industry With the Highest EBITDA Growth (BMRN, ALXN, CELG, RGEN, LGND)

By Nick Russo

Below are the three companies in the Biotechnology industry with the highest EBITDA Growth (next year estimate vs. LTM). EBITDA Growth can be valuable in predicting future cash flow generation and earnings power.

Biomarin Pharmac ranks highest with a EBITDA growth of 156.0%. Alexion Pharm is next with a EBITDA growth of 121.4%. Celgene Corp ranks third highest with a EBITDA growth of 116.7%.

Repligen Corp follows with a EBITDA growth of 103.7%, and Ligand Pharm rounds out the top five with a EBITDA growth of 45.6%.

SmarTrend recommended that subscribers consider buying shares of Celgene Corp on August 26th, 2019 as our technology indicated a new Uptrend was in progress when shares hit $97.27. Since that recommendation, shares of Celgene Corp have risen 11.3%. We continue to monitor Celgene Corp for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: highest ebitda growth biomarin pharmac alexion pharm celgene corp repligen corp ligand pharm

Ticker(s): BMRN ALXN CELG RGEN LGND